GSK terminates collaboration with Alector after trial failures
Go back to GSK terminates collaboration with Alector after trial failures| (NASDAQ: ALEC) | Delayed: 1.52 +0.01 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.51 | 52 Week High | $ | |||
| Open | $1.51 | 52 Week Low | $ | |||
| Day High | $1.53 | P/E | N/A | |||
| Day Low | $1.48 | EPS | $ | |||
| Volume | 142,090 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 53.94 +1.96 (3.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.98 | 52 Week High | $45.58 | |||
| Open | $54.24 | 52 Week Low | $37.82 | |||
| Day High | $55.79 | P/E | N/A | |||
| Day Low | $53.60 | EPS | $0.00 | |||
| Volume | 5,814,684 | |||||
